Search Results

Stanford Cancer Institute Stanford Cancer Institute member Julien Sage, PhD, is the senior author on a study showing that lung cancer cells that metastasize to the brain survive by convincing brain cells called astrocytes that they are baby neurons in need of protection. Read More

Fox Chase Cancer Center, Temple Health Fox Chase Cancer Center's Carolyn Fang, PhD, and Grace Ma, PhD, of the Lewis Katz School of Medicine at Temple University, will serve as two of the principal investigators (PIs) on the Asian American Community Cohort and Equity Study, part of a new seven-year, $4.4 million epidemiological cohort study of Asian Americans, Native Hawaiians, and Pacific Islanders. The study is funded by the National Heart, Lung, and Blood Institute. Read More

University of Illinois Cancer Center The University of Illinois Chicago will be the first site in the state to participate in a national study of a clinical test that screens for a shared cancer signal in a sample of patient blood. The University of Illinois Cancer Center and the UI Health Mile Square Health Center will enroll patients in the PATHFINDER 2 trial led by the biotechnology company GRAIL. Read More

University of Florida Health Cancer Center A team of UF Health Cancer Center researchers has discovered how modifications to a specific type of RNA play a crucial role in lung cancer. By modifying the RNA in laboratory cells, the researchers were able to inhibit the growth of lung cancer cells. Read More

Roswell Park Comprehensive Cancer Center An advanced, high-speed blood cancer test developed at Roswell Park Comprehensive Cancer Center has been licensed for commercial development by Agilent Technologies Inc. PanHeme, an assay used to support the clinical care of patients with blood cancers, can identify mutations in hundreds of genes in under 72 hours. Read More

Vanderbilt-Ingram Cancer Center A multidisciplinary team of investigators that will probe the connection between obesity and cancer has received a 2023 Endeavor Award from The Mark Foundation for Cancer Research. The three-year, $3 million award will support four closely linked projects exploring the fundamental mechanisms that drive the obesity-cancer connection, taking advantage of a collection of matched tumor and adipose tissue samples from patients. Read More

Hollings Cancer Center, Medical University of South Carolina Marvella Ford, PhD, has been recognized by Modern Healthcare as one of 2023’s Top Diversity Leaders. Dr. Ford is associate director of Population Science and Community Outreach and Engagement for MUSC Hollings Cancer Center. Read More

Winship Cancer Institute of Emory University The newly established $100,000 Emory Max Cooper Prize in Immunology celebrates the groundbreaking contributions of Max D. Cooper, MD, a member of the Cancer Immunology Research Program at Winship Cancer Institute of Emory University, whose research and discoveries have changed our understanding of the adaptive immune system, including its impact on cancer. Read More

Comprehensive Cancer Center St. Jude Children's Research Hospital Using data from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort Study, scientists at St. Jude Children’s Research Hospital have identified a genetic explanation for why a small proportion of survivors are more likely to develop second cancers and why they may be more severe or deadly. Read More

Cedars-Sinai Cancer Cedars-Sinai Cancer investigators have found that Black men respond as well as white men to systemic therapies for advanced prostate cancer when access to quality health care is equal, regardless of socioeconomic status. Read More

Wilmot Cancer Institute, UR Medicine Patrick M. Reagan, MD, associate professor of medicine, has been named director of the Blood & Marrow Transplant and Cellular Therapies program at Wilmot Cancer Institute. Since Wilmot’s BMT program started in 1989, it has performed more than 4,400 transplants. Read More

University of Virginia Cancer Center The University of Virginia School of Medicine has named Lu Q. Le, MD, PhD, a cancer biology researcher, to chair its Department of Dermatology. He will begin January 29, 2024. Dr. Le joins UVA from the University of Texas Southwestern Medical Center. Read More

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine Xiang "Shawn" Zhang, PhD, has been named director of the Lester and Sue Smith Breast Center at Baylor College of Medicine after serving as interim director since March 2022. Dr. Zhang is a professor of molecular and cellular biology and a McNair Scholar at Baylor. Read More

Huntsman Cancer Institute at the University of Utah The National Cancer Institute awarded investigators at Huntsman Cancer Institute a grant totaling more than $3 million to conduct a clinical trial to see if combining creatine monohydrate supplementation and resistance exercise training helps preserve muscle in people who have metastatic prostate cancer. Read More

Indiana University Melvin and Bren Simon Comprehensive Cancer Center Liz Yeh, PhD, of the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, received a five-year, $2.2 million grant from the National Cancer Institute to examine how certain immune cells support metastatic breast cancer development – and how to stop it. Read More

The University of Kansas Cancer Center Translational research bridges the gap between basic research and its real-world application in clinical settings. The process involves interdisciplinary collaboration, substantial funding and often, years of effort. To grow and train future clinical and translational scientists, The University of Kansas Cancer Center has received a $2.4 million grant from the National Cancer Institute. Read More

The University of Kansas Cancer Center Simon Craddock Lee, PhD, MPH, chair and Sosland Family Professor in Preventive Medicine in the Department of Population Health, has been named interim associate director for Cancer Workforce Equity at The University of Kansas Cancer Center. Read More

City of Hope Comprehensive Cancer Center Scientists with City of Hope and the Translational Genomics Research Institute, part of City of Hope, may have discovered one of the causes for a type of leukemia to develop into a more aggressive form, according to a recent paper. Researchers analyzed the RNA of chronic myeloid leukemia cells and found that miR-142, an RNA molecule that regulates cell metabolism, was missing. Read More

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine Researchers at Baylor College of Medicine have identified a small molecule named 5D4 that can suppress the growth of breast and ovarian cancers in animal models. 5D4 works by binding to TopBP1 protein in cancer cells, disrupting its interactions with several pathways that promote cancer growth. Read More

Huntsman Cancer Institute at the University of Utah Huntsman Cancer Institute (HCI) at the University of Utah and Utah Valley University announce a partnership called the "Huntsman Cancer Institute–Utah Valley University Health Collaborative," supported by a $1 million donation from HCI. The program marks a significant step towards revolutionizing health and science education. Read More

The Tisch Cancer Institute at Mount Sinai Sundar Jagannath, MD, has been honored with the Waldenström Lifetime Achievement Award from the International Myeloma Society in recognition of his contributions to research and clinical advances in multiple myeloma. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Using laboratory-grown cells from humans and genetically engineered mice, scientists at Johns Hopkins Medicine say they have evidence that modifying a specific protein in immune white blood cells known as CD8+ T cells can make the cells more robust, potentially opening the door for better use of people’s own immune system T cells to fight cancer. Read More

UK Markey Cancer Center With the creation of Cancer InFocus, UK Markey Cancer Center’s Community Impact Office introduced a new tool monitoring the geographic burden of cancer. Launched in 2022, this resource combines powerful data collection software with an interactive online application to accelerate gaining insight from data in the fight against cancer. Read More

UCLA Jonsson Comprehensive Cancer Center UCLA researchers have developed a new treatment method using a tiny nanocapsule to help boost the immune response, making it easier for the immune system to fight and kill solid tumors. Investigators found the approach increased the number and activity of immune cells that attack the cancer, making cancer immunotherapies work better. Read More

University of New Mexico Comprehensive Cancer Center For Gladys Tsao-Wu, MD, and Jennifer Chan, MD, reconstruction is as much about helping patients recover emotionally as it is about physical restoration. After more than a decade working together in private practice, the duo has joined UNM Comprehensive Cancer Center to help breast cancer survivors reclaim what cancer took from them. Read More

Moffitt Cancer Center BioFlorida Inc., a statewide association linking more than 8,600 of Florida’s research organizations and establishments in the biopharma, MedTech, digital health and health systems, has named W. Gregory Sawyer, PhD, Moffitt Cancer Center’s chief bioengineering officer, its Entrepreneur of the Year. Read More

Fox Chase Cancer Center, Temple Health Igor Astsaturov, MD, PhD, co-director of The Marvin and Concetta Greenberg Pancreatic Cancer Institute at Fox Chase Cancer Center, has been appointed inaugural holder of the Paul F. Engstrom Professorship in Oncology. Read More

University of Florida Health Cancer Center As part of its continued development as a National Cancer Institute-Designated Cancer Center, the University of Florida Health Cancer Center has expanded its research programs, including leveraging technology such as robot-assisted drug discovery to complement pharmacogenomics research at UF. Read More

UAMS Winthrop P. Rockefeller Cancer Institute The Willard & Pat Walker Charitable Foundation has pledged $1 million to the UAMS Winthrop P. Rockefeller Cancer Institute. The funds will support the cancer institute’s new Radiation Oncology Center, which opened in July. Read More

AACI prioritizes engagement with key issues that impact our nation's cancer centers. Throughout October, AACI participated in meetings and advocacy events in Washington, DC, partnering with the Hematology/Oncology Pharmacy Association, One Voice Against Cancer, and United for Medical Research. Pictured, top to bottom: Representative Steve Womack and Senator Shelley Moore Capito. Photo credit: Ollie Mae Nicholl for UMR. Read More

Indiana University Melvin and Bren Simon Comprehensive Cancer Center The Indiana University Melvin and Bren Simon Comprehensive Cancer Center was awarded a prestigious grant to train the next generation of cancer drug discovery and development researchers. The five-year National Cancer Institute award will establish the Pediatric and Adult Translational Cancer Drug Discovery and Development Training Program. Read More

UCSF Helen Diller Family Comprehensive Cancer Center A new paper reports findings of a multi-center retrospective study that compares bone scan with PSMA PET for initial staging of prostate cancer, noting overstaging for metastasis—when local disease is a more accurate diagnosis—may subject patients to treatments that increase therapy-related morbidity. Read More

GW Cancer Center Jennifer Vaz, MD, has joined the GW University Cancer Center and the GW Medical Faculty Associates as a gynecological oncologist. She specializes in malignant and benign tumors of the pelvis, including ovarian, uterine, cervical, and vulvar/vaginal malignancies. Read More

As a leader in specialty care, Integra Connect leverages powerful AI and unprecedented expertise for oncology research and industry to: Improve care Embrace scientific advances Manage costs Deliver innovations Learn more about how quality initiatives are driving improvements at the point of care and beyond. Watch Now

Northwell Health Cancer Institute Northwell Health has opened a suite of medical practices meant to cover a host of conditions and deliver complex, coordinated health care in the heart of Queens. The $52 million, 70,000-square-foot facility is easily reachable by car, subway, or bus line and anchored by the largest outpatient cancer center in the borough.   Read More

UMMC Cancer Center and Research Institute The epic fight against cancer is personal for University of Mississippi alumnus Rodney Rocconi, MD. He was appointed director of the UMMC Cancer Center and Research Institute in July, following 16 years in various leadership roles at the University of South Alabama Mitchell Cancer Institute. Read More

Duke Cancer Institute, Duke University Medical Center The White House Cancer Moonshot program has signaled its support for a new initiative led by TOUCH, to bolster Black women’s breast cancer clinical trial participation by 2025. The White House also highlighted a connected program, TOUCH Care, led by Valarie Worthy, MSN, RN, that provides nurse navigator services to assist Black breast cancer patients in clinical trials. Read More

Vanderbilt-Ingram Cancer Center Debra Friedman, MD, MS, holder of the E. Bronson Ingram Chair in Pediatric Oncology, has been named deputy director of Vanderbilt-Ingram Cancer Center. Dr. Friedman serves as associate director for Community Science and Health Outcomes for Vanderbilt-Ingram and served as a research program leader for Vanderbilt-Ingram from 2008-2023. Read More

To accelerate the attainment of the first National Cancer Institute (NCI)-Designated Cancer Center in Louisiana, LSU Health, LCMC Health, Louisiana Cancer Research Center (LCRC), and Tulane University have aligned and signed an agreement that Joe W. Ramos, PhD, will serve as director of the LSU LCMC Health Cancer Center. Read More

Fred Hutchinson Cancer Center When Reiko Horst was diagnosed with early-stage breast cancer, she knew next to nothing about the disease. To help determine the best treatment plan, her medical oncologist at Fred Hutchinson Cancer Center recommended doing a test called Oncotype DX to help predict Horst’s risk of the cancer returning and the benefit of chemotherapy. Read More

LSU LCMC Health Cancer Center Governor John Bel Edwards has announced a new statewide collaboration among LSU, LCMC Health, Louisiana Cancer Research Center, and Tulane University to accelerate the attainment of the first National Cancer Institute (NCI)-Designated Cancer Center in Louisiana. Read More

Roswell Park Comprehensive Cancer Center Three National Cancer Institute grants totaling $13.5 million will support the Roswell Park Comprehensive Cancer Center team leading a multi-institutional effort aimed at improving the potential of immune checkpoint inhibitors. Working with the University of Rochester’s Wilmot Cancer Institute and Kaiser Permanente Northern California Division of Research, Roswell Park will expand on work to understand differences in how cancer patients of differe…

Alec Kimmelman, MD, PhD, a renowned researcher and radiation oncologist, has been named director of the Laura and Isaac Perlmutter Cancer Center. Dr. Kimmelman will also retain his title as the Anita Steckler and Joseph Steckler Chair of the Department of Radiation Oncology at NYU Grossman School of Medicine. This appointment is effective immediately. Read More

Fox Chase Cancer Center, Temple Health Temple University/Fox Chase Cancer Center and Hunter College of the City University of New York have received a five-year, $13.3 million competitive grant renewal from the National Cancer Institute to address cancer health disparities. Read More

Sidney Kimmel Cancer Center at Jefferson Health Jefferson Health is joining the Department of Veterans Affairs (VA), alongside 12 other community health care systems, to share data to improve the veteran experience regardless of where veterans receive their health care – inside or outside of the VA. Read More

The University of Arizona Cancer Center What if you could use human cells in their own microenvironment to discover how prostate cancer begins, metastasizes to bone, and develops drug resistance? Cynthia Miranti, PhD, and her team are doing just that by developing the first successful Prostate-on-a-Chip model that recreates the development and differentiation processes that occur in a normal human prostate gland. Read More

University of Michigan Rogel Cancer Center Experts at the University of Michigan Health Rogel Cancer Center have found a potential solution for preventing a common and dangerous complication in patients that receive stem cell transplants from a donor’s blood or bone marrow. Read More

Comprehensive Cancer Center St. Jude Children's Research Hospital Giles Robinson, MD, has assumed the role of director for the Department of Oncology’s Division of Neuro-Oncology. He has also become co-leader of the Neurobiology and Brain Tumor Program within the St. Jude Comprehensive Cancer Center. Read More

Mayo Clinic Comprehensive Cancer Center Mayo Clinic Comprehensive Cancer Center and Columbia University received a five-year, $10.6 million U54 center grant from the National Cancer Institute to further study combining the molecular analysis of glioblastoma with MRI. Read More

On November 17, President Joe Biden announced his nomination of W. Kimryn Rathmell, MD, PhD, MMHC, to be the next director of the National Cancer Institute (NCI). She will be the NCI’s 17th director and only the second woman to hold this position. Dr. Rathmell is the Hugh Jackson Professor of Medicine and chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC). She joined VUMC in 2015 as director of the Division of Hematology and Oncology.  Read More

The University of Kansas Cancer Center is seeking a Postdctoral Fellow for its Community Outreach & Engagement program. The University of Kansas Cancer Center is the region's only National Cancer Institute-designated cancer center where patients gain access to the most promising therapies, cutting-edge clinical trials and world class research. The Postdoctoral Fellow will work under the supervision of Dr. Ronald Chen, Joe and Jean Brandmeyer Endowed Professor and KUCC Associate Director o…

The University of Chicago Medicine Comprehensive Cancer Center Trans-vaccenic acid, a long-chain fatty acid found in meat and dairy products from grazing animals such as cows and sheep, improves the ability of CD8+ T cells to infiltrate tumors and kill cancer cells, according to a new study by researchers from the University of Chicago. Read More

UCLA Jonsson Comprehensive Cancer Center Investigators from the UCLA Health Jonsson Comprehensive Cancer Center have developed an artificial intelligence (AI) model based on epigenetic factors that is able to predict patient outcomes successfully across multiple cancer types. Read More

Registration is now open for AACI’s 2024 Leadership Diversity and Development Workshop (LDDW), which will be held March 12-13 at Loews Chicago O’Hare Hotel. AACI cancer center directors are encouraged to select one emerging leader from their center to attend. Read More

Stony Brook Cancer Center A team of Stony Brook University researchers, led by Gábor Balázsi, PhD, have been testing drug resistance with mammalian cell lines. Their latest investigation reveals that by taking a part of a DNA amplification from a cell, which causes resistance, and placing it back in, actually stops the drug resistance. Read More

Montefiore Einstein Comprehensive Cancer Center Researchers at Montefiore Einstein Comprehensive Cancer Center were recently awarded a four-year, $2.6 million grant from the U.S. Food and Drug Administration to conduct an innovative Phase I clinical trial of a new drug for patients with relapsed and treatment-resistant forms of acute myeloid leukemia and myelodysplastic syndromes. Read More

The National Cancer Institute (NCI) provides grants to state cancer centers and universities, enabling these institutions to fund innovative research. Below are some recent success stories of NCI-funded projects at AACI cancer centers.

Roswell Park Comprehensive Cancer Center A Phase I clinical trial conducted exclusively at Roswell Park Comprehensive Cancer Center shows that a novel treatment regimen can make immunotherapy more effective in patients with metastatic triple-negative breast cancer. Read More

Stanford Cancer Institute Stanford Cancer Institute researchers have found that national guidelines for lung cancer screening are less effective for African Americans than for whites, and a risk-based analysis is more equitable and effective. Read More

Georgetown Lombardi Comprehensive Cancer Center Reducing health disparities in incidence and mortality for major types of cancers can be aided by sophisticated computer modeling efforts, according to new, wide-ranging perspectives from researchers at Georgetown University’s Lombardi Comprehensive Cancer Center and colleagues around the country. Read More

UCSF Helen Diller Family Comprehensive Cancer Center Researchers at UC San Francisco and Northwestern Medicine, in collaboration with 10 other medical centers, have found a highly accurate way to predict the best treatment for patients based on patterns of gene expression in their tumors. Screening tumors using this new approach could change the course of treatment for nearly 1 in 3 people with meningioma. Read More

Winship Cancer Institute of Emory University Launched in November under the umbrella of Emory University's AI.Humanity initiative, the Emory Empathetic AI for Health Institute will be led by Anant Madabhushi, PhD, a member of the Cancer Immunology research program at Winship Cancer Institute. Read More

The University of Vermont Cancer Center Diego Adrianzen Herrera, MD, assistant professor of medicine, has been appointed to serve as associate director of diversity, equity, and inclusion (DEI) for the University of Vermont Cancer Center. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University A new pathologic scoring system that accurately assesses how much lung tumor is left after a patient receives presurgical cancer treatments can be used to predict survival, according to investigators at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center and the Mark Foundation Center for Advanced Genomics and Imaging at the Johns Hopkins University. Read More

University of Michigan Rogel Cancer Center Findings from researchers at the University of Michigan Health Rogel Cancer Center show how a specific nucleotide metabolite, called GTP, controls responses to radiation and chemotherapy in an unexpected way. Read More

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute A new targeted drug, studied by researchers at OSUCCC - James, may offer a new treatment option for patients with blood cancers, including chronic lymphocytic leukemia and non-Hodgkin lymphoma, whose disease has stopped responding to standard treatments. Read More

Moffitt Cancer Center Moffitt Cancer Center has announced Jeremy Goecks, PhD, as its assistant center director of research informatics. Dr. Goecks will lead adoption of innovative technology platforms and computing standards within the data-related core services, as well as transition research innovations to clinical applications through the Center of Digital Health. Read More

Indiana University Melvin and Bren Simon Comprehensive Cancer Center Two researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have received a five-year, $2.4 million grant from the National Cancer Institute to explore new therapies that target the critical pathways pancreatic tumors use to survive. Read More

Fox Chase Cancer Center, Temple Health Alexander Kutikov, MD, FACS, chair of the Department of Urology at Fox Chase Cancer Center, has received the Andrew C. Novick Award from the Kidney Cancer Association. Read More

Duke Cancer Institute, Duke University Medical Center A Duke Health analysis of breast cancer in North Carolina showed that the state’s urban counties had higher overall incidences of disease than rural counties, especially at early stages upon diagnosis. The findings serve as a national template for assessing the impact of poor environmental quality across different stages of breast cancer. Read More

USC Norris Comprehensive Cancer Center In the United States, liver cancer rates have more than tripled since 1980. Some groups, including Latinos, face an even higher risk than the general population. A study from the Keck School of Medicine of USC, funded by the National Cancer Institute, has found that among Mexican Americans, liver cancer risk rises the longer a person’s family has lived in the U.S. That increased risk primarily affected men. Read More

Winship Cancer Institute of Emory University The new Georgia Blood Cancer Trials Network will make innovative, investigational therapies and treatments more accessible to Georgia patients with blood cancer who reside outside of metropolitan Atlanta. The network is supported by an approximately $2 million grant from The Leukemia & Lymphoma Society. Read More

The Tisch Cancer Institute at Mount Sinai Joseph Sparano, MD, received the Ezra Greenspan Award from The Chemotherapy Foundation for his groundbreaking work in breast cancer and HIV-related malignancies, and his work to address cancer disparities in vulnerable populations. Dr. Sparano is chair of the Division of Hematology and Medical Oncology at Icahn Mount Sinai and deputy director of The Tisch Cancer Institute. Read More

Stanford Cancer Institute Stanford Cancer Institute member Michelle Monje, MD, PhD, led a study that found that neuron activity influences the growth of gliomas through various signaling factors. Read More

University of Florida Health Cancer Center A new paper describes the discovery of two new enzymes, ones with uniquely useful properties that could help in the fight against human diseases including cancer. The research offers potentially easier ways to study and manufacture complex natural chemicals, including those that could become medicines. Read More

UK Markey Cancer Center With a $2 million grant from the National Institutes of Health, a UK Markey Cancer Center researcher is working to develop new techniques for radiation treatment to improve survival rates of patients with a specific type of cancer. Read More

The Fred Hutchinson Cancer Center (Fred Hutch) is recruiting a full-time faculty member at the Assistant, Associate or Full Professor level in the Public Health Sciences or Clinical Research Division at Fred Hutch whose work is focused on cancer research in Indigenous, American Indian, and/or Alaska Native populations. Areas of research could include but are not limited to primary prevention, cancer screening and early detection, etiology, survivorship, social determinants of health, behavioral…

UK Markey Cancer Center UK Markey Cancer Center researcher Yasminka A. Jakubek, PhD, has led the first large-scale effort to understand the co-occurrence of mosaic chromosomal alterations among individuals of diverse ancestries. Read More

USC Norris Comprehensive Cancer Center A globe-spanning scientific team has compiled the most comprehensive list of genetic variants associated with prostate cancer risk—451 in all—through a whole-genome analysis that ranks as the largest and most diverse investigation into prostate cancer genetics yet. Read More

UC Davis Comprehensive Cancer Center New research led by a UC Davis Comprehensive Cancer Center clinical scientist shows blood tests used to hunt for cancer DNA may help detect cancers faster and guide the use of targeted therapies. Read More

Indiana University Melvin and Bren Simon Comprehensive Cancer Center Huda Salman, MD, PhD, has been awarded a $1 million grant from the Leukemia & Lymphoma Society to evaluate a new treatment for an extremely rare and incurable blood cancer. Read More

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute Oral nicotine pouches, a tobacco leaf-free product marketed as an alternative to cigarettes, do little to curb current smokers’ nicotine cravings, according to a new study. Read More

Comprehensive Cancer Center St. Jude Children's Research Hospital Scientists at St. Jude have validated a cellular immunotherapy target called 78-kDa glucose-regulated protein (GRP78) in proof-of-principle experiments. The group also discovered a resistance mechanism whereby some tumors trick the cancer-killing immune cells into expressing GRP78, thereby turning off the immune cells or causing them to be killed, too. Read More

UCSF Helen Diller Family Comprehensive Cancer Center UC San Francisco researchers have analyzed data from over five million screening and diagnostic mammograms to develop an updated BCSC model for invasive breast cancer to include additional risk factors including body mass index, second degree relatives with a family history of breast cancer, and age at first live birth to improve model prediction. Read More

UCLA Jonsson Comprehensive Cancer Center Among the nation’s hospitals, those that serve high numbers of Black and Hispanic patients are far less likely to have advanced medical equipment and critical services that have been shown to boost the quality and effectiveness of cancer care, according to a study led by investigators at UCLA Jonsson Comprehensive Cancer Center. Read More

The University of Chicago Medicine Comprehensive Cancer Center In ovarian cancer, fat cells adjacent to cancer cells reprogram the glucose metabolic pathway through hypoxia-inducible factor 1α to promote metastasis, according to a new study. Researchers at the University of Chicago Medicine Comprehensive Cancer Center set out to understand how abdominal cancers spread and how cancer cells rely on/deploy energy sources like sugar and fat to survive. Read More

Moffitt Cancer Center Tiffany Carson, PhD, MPH, is the new co-leader of the Moffitt Cancer Center& Health Outcomes & Behavior Program. The goal of the program is to improve cancer outcomes by better understanding individuals, health care systems, and communities. This includes developing interventions to assist with cancer prevention and survivorship. Read More

Continuing its engagement with issues that affect the cancer center community, AACI staff attended several events in Washington, DC, last month. Following the Friends of Cancer Research Annual Meeting on Tuesday, November 14, AACI participated in advocacy events promoting HPV- and lung cancer-related legislation. Read More

Please apply for this role at: https://careers-fhcrc.icims.com/jobs/26616/director%2c-regulatory-operations/job Overview Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.  The Regulatory Operations Director oversees the Central Regulatory operations team within t…

Environmental Health Open Rank Faculty (Cancer focused) Assistant Professor, Associate Professor, Professor – Tenure We seek candidates with expertise or prior experience in at least two of the following: (1) community-engaged research investigating the toxicological effects of environmental or occupational hazards with an emphasis on cancer outcomes; (2) environmental and biological monitoring to assess multi-pathway exposures to industrial, agricultural and/or transportation related hazards;…

Community Health Open Rank Faculty (Cancer focused) Assistant Professor, Associate Professor, Professor LSU Health New Orleans and the School of Public Health are growing their cancer-related programs, and as such, are seeking candidates for open rank faculty positions in the Community Health Sciences and Policy Program (CHSP) with expertise in cancer and community outreach and engagement.   We are seeking candidates with prior experience or expertise in at least one of the following: (1) mult…

AACI President Robert A. Winn, MD, director of VCU Massey Comprehensive Cancer Center, has appointed community advocates Rudene Haynes, JD, and Loriana Hernández-Aldama to the steering committee of his Inclusive Excellence Initiative. Read More

Vice President, DEI Strategy, Insights, and Innovation APPLY NOW Location Washington D.C., District of ColumbiaPosition Type Full-time  At the American Cancer Society, we're leading the fight for a world without cancer. Our employees and 1.5 million volunteers are raising the bar every single day. We actively seek candidates from diverse backgrounds including communities of color, the LGBTQ community, veterans, and people with disabilities. The greater the diversity of our people, the better…

Astound is your personal funding scout for all sources of non-federal research funding. Astound’s AI-powered service matches you to the best research and industry funding opportunities. Create a profile, upload your CV or Biosketch, and we’ll keep you updated on all the best matches. Use the code AACI2023 to get 25% off between now and the end of the year! Learn More

The AACI CRI Steering Committee is currently soliciting abstracts for the 16th Annual AACI CRI Meeting. This year’s meeting theme will focus on compassion and collaboration through clinical trials. The purpose of the abstracts is to inform meeting attendees about clinical trials office challenges and solutions implemented at AACI cancer centers. Read More

University of New Mexico Comprehensive Cancer Center The UNM Comprehensive Cancer Center, led by Yolanda Sanchez, PhD, has broken ground on a $61 million clinic building addition. The expansion will make room for advanced radiation treatment machines, theranostic treatment rooms, interventional radiology procedures, and cellular therapies. Dr. Sanchez is a member of AACI's Board of Directors. Read More